Assessing the Percent of Necrosis after Neoadjuvant Chemotherapy with 24hr Infusional Cisplatin/3 Days Doxorubicin Intermittent with Ifosfamide-Doxorubicin for Osteosarcoma

INTRODUCTION: Osteosarcoma is the most common primary bone tumor in children and young adults and appropriate chemotherapy can increase limb sparing and overall survival. Yet, the toxicity of chemotherapy regimens including MTX can be life threatening. Therefore; we tried another chemotherapy regime...

Descripción completa

Detalles Bibliográficos
Autores principales: Samimi, Mozhgan Aalam, Mirkheshti, Nooshin, Pazouki, Abdolreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913158/
https://www.ncbi.nlm.nih.gov/pubmed/24505545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913158/
https://www.ncbi.nlm.nih.gov/pubmed/24505545

Ejemplares similares